Europe Pharma 4.0 Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Technology, By Country and Growth Forecast, 2024

List of Tables

The Europe Pharma 4.0 Market would witness market growth of 18.3% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Pharma 4.0 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,406.6 million by 2031. The UK market is exhibiting a CAGR of 17.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 19.5% during (2024 - 2031).

Data analytics also plays a central role in this 4.0. The pharmaceutical industry generates an immense volume of data during the various stages of drug development, including research, clinical trials, production, and distribution. With big data analytics, companies can derive actionable insights from these datasets, enabling more informed decisions and process optimization.

Automation and robotics are also transforming pharmaceutical production under this 4.0. Automated systems can perform ingredient mixing, tablet pressing, and packaging more precisely and quickly than human workers. This enhances productivity and mitigates the likelihood of contamination and errors. Collaborative robots, or "cobots," are being increasingly adopted in pharmaceutical facilities to work alongside human operators, handling repetitive tasks and freeing up workers for more complex roles.

The European Union (EU) has recognized the transformative potential of this 4.0 and is actively promoting its growth through region-wide initiatives. The "Horizon Europe" program, which has allocated €93.5 billion for research and innovation from 2021 to 2027, includes substantial funding for digital health and pharmaceutical technologies. This program aims to enhance collaboration between member states, fostering innovation in AI, IoT, and data analytics within the pharmaceutical sector. Hence, this combination of national initiatives and EU-wide support reflects a growing demand for Pharma 4.0 technologies across Europe.

Based on Type, the market is segmented into Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Manufacturing, Supply Chain Management, and Other Application. Based on End Use, the market is segmented into Pharma & Biotech companies, CRO & CDMO, and Healthcare Providers. Based on Technology, the market is segmented into AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Amazon Web Services, Inc.
SAP SE
Oracle Corporation
Microsoft Corporation
IBM Corporation
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cisco Systems, Inc.
Dassault Systemes SE
UnitedHealth Group, Inc. (Optum, Inc.)

Europe Pharma 4.0 Market Report Segmentation

By Type

Software
Services

By Application

Drug Discovery & Development
Manufacturing
Supply Chain Management
Other Application

By End Use

Pharma & Biotech companies
CRO & CDMO
Healthcare Providers

By Technology

AI & ML
Big Data Analytics
IoT
Blockchain Technology
Other Technology

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Pharma 4.0 Market, by Type
- 1.4.2 Europe Pharma 4.0 Market, by Application
- 1.4.3 Europe Pharma 4.0 Market, by End Use
- 1.4.4 Europe Pharma 4.0 Market, by Technology
- 1.4.5 Europe Pharma 4.0 Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, May - 2024, Sep) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. Europe Pharma 4.0 Market by Type

5.1 Europe Software Market by Country
5.2 Europe Services Market by Country

Chapter 6. Europe Pharma 4.0 Market by Application

6.1 Europe Drug Discovery & Development Market by Country
6.2 Europe Manufacturing Market by Country
6.3 Europe Supply Chain Management Market by Country
6.4 Europe Other Application Market by Country

Chapter 7. Europe Pharma 4.0 Market by End Use

7.1 Europe Pharma & Biotech companies Market by Country
7.2 Europe CRO & CDMO Market by Country
7.3 Europe Healthcare Providers Market by Country

Chapter 8. Europe Pharma 4.0 Market by Technology

8.1 Europe AI & ML Market by Country
8.2 Europe Big Data Analytics Market by Country
8.3 Europe IoT Market by Country
8.4 Europe Blockchain Technology Market by Country
8.5 Europe Other Technology Market by Country

Chapter 9. Europe Pharma 4.0 Market by Country

9.1 Germany Pharma 4.0 Market
- 9.1.1 Germany Pharma 4.0 Market by Type
- 9.1.2 Germany Pharma 4.0 Market by Application
- 9.1.3 Germany Pharma 4.0 Market by End Use
- 9.1.4 Germany Pharma 4.0 Market by Technology
9.2 UK Pharma 4.0 Market
- 9.2.1 UK Pharma 4.0 Market by Type
- 9.2.2 UK Pharma 4.0 Market by Application
- 9.2.3 UK Pharma 4.0 Market by End Use
- 9.2.4 UK Pharma 4.0 Market by Technology
9.3 France Pharma 4.0 Market
- 9.3.1 France Pharma 4.0 Market by Type
- 9.3.2 France Pharma 4.0 Market by Application
- 9.3.3 France Pharma 4.0 Market by End Use
- 9.3.4 France Pharma 4.0 Market by Technology
9.4 Russia Pharma 4.0 Market
- 9.4.1 Russia Pharma 4.0 Market by Type
- 9.4.2 Russia Pharma 4.0 Market by Application
- 9.4.3 Russia Pharma 4.0 Market by End Use
- 9.4.4 Russia Pharma 4.0 Market by Technology
9.5 Spain Pharma 4.0 Market
- 9.5.1 Spain Pharma 4.0 Market by Type
- 9.5.2 Spain Pharma 4.0 Market by Application
- 9.5.3 Spain Pharma 4.0 Market by End Use
- 9.5.4 Spain Pharma 4.0 Market by Technology
9.6 Italy Pharma 4.0 Market
- 9.6.1 Italy Pharma 4.0 Market by Type
- 9.6.2 Italy Pharma 4.0 Market by Application
- 9.6.3 Italy Pharma 4.0 Market by End Use
- 9.6.4 Italy Pharma 4.0 Market by Technology
9.7 Rest of Europe Pharma 4.0 Market
- 9.7.1 Rest of Europe Pharma 4.0 Market by Type
- 9.7.2 Rest of Europe Pharma 4.0 Market by Application
- 9.7.3 Rest of Europe Pharma 4.0 Market by End Use
- 9.7.4 Rest of Europe Pharma 4.0 Market by Technology

Chapter 10. Company Profiles

10.1 Amazon Web Services, Inc. (Amazon.com, Inc.)
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental Analysis
- 10.1.4 Recent strategies and developments:
  - 10.1.4.1 Partnerships, Collaborations, and Agreements:
- 10.1.5 SWOT Analysis
10.2 Oracle Corporation
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Partnerships, Collaborations, and Agreements:
  - 10.2.5.2 Acquisition and Mergers:
- 10.2.6 SWOT Analysis
10.3 Microsoft Corporation
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 Recent strategies and developments:
  - 10.3.5.1 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
10.4 IBM Corporation
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional & Segmental Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
  - 10.4.5.1 Partnerships, Collaborations, and Agreements:
  - 10.4.5.2 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
10.5 SAP SE
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
  - 10.5.5.1 Partnerships, Collaborations, and Agreements:
  - 10.5.5.2 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
10.6 GE HealthCare Technologies, Inc.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 Recent strategies and developments:
  - 10.6.5.1 Product Launches and Product Expansions:
- 10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 Recent strategies and developments:
  - 10.7.5.1 Partnerships, Collaborations, and Agreements:
- 10.7.6 SWOT Analysis
10.8 Cisco Systems, Inc.
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expense
- 10.8.5 Recent strategies and developments:
  - 10.8.5.1 Partnerships, Collaborations, and Agreements:
- 10.8.6 SWOT Analysis
10.9 Dassault Systemes SE
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expense
- 10.9.5 Recent strategies and developments:
  - 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
10.10. UnitedHealth Group, Inc. (Optum, Inc.)
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Segmental Analysis

LIST OF TABLES

TABLE 1 Europe Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 2 Europe Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Pharma 4.0 Market
TABLE 4 Product Launches And Product Expansions- Pharma 4.0 Market
TABLE 5 Acquisition and Mergers- Pharma 4.0 Market
TABLE 6 Europe Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 7 Europe Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 8 Europe Software Market by Country, 2020 - 2023, USD Million
TABLE 9 Europe Software Market by Country, 2024 - 2031, USD Million
TABLE 10 Europe Services Market by Country, 2020 - 2023, USD Million
TABLE 11 Europe Services Market by Country, 2024 - 2031, USD Million
TABLE 12 Europe Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 13 Europe Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 14 Europe Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 15 Europe Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 16 Europe Manufacturing Market by Country, 2020 - 2023, USD Million
TABLE 17 Europe Manufacturing Market by Country, 2024 - 2031, USD Million
TABLE 18 Europe Supply Chain Management Market by Country, 2020 - 2023, USD Million
TABLE 19 Europe Supply Chain Management Market by Country, 2024 - 2031, USD Million
TABLE 20 Europe Other Application Market by Country, 2020 - 2023, USD Million
TABLE 21 Europe Other Application Market by Country, 2024 - 2031, USD Million
TABLE 22 Europe Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 23 Europe Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 24 Europe Pharma & Biotech companies Market by Country, 2020 - 2023, USD Million
TABLE 25 Europe Pharma & Biotech companies Market by Country, 2024 - 2031, USD Million
TABLE 26 Europe CRO & CDMO Market by Country, 2020 - 2023, USD Million
TABLE 27 Europe CRO & CDMO Market by Country, 2024 - 2031, USD Million
TABLE 28 Europe Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 29 Europe Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 30 Europe Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 31 Europe Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 32 Europe AI & ML Market by Country, 2020 - 2023, USD Million
TABLE 33 Europe AI & ML Market by Country, 2024 - 2031, USD Million
TABLE 34 Europe Big Data Analytics Market by Country, 2020 - 2023, USD Million
TABLE 35 Europe Big Data Analytics Market by Country, 2024 - 2031, USD Million
TABLE 36 Europe IoT Market by Country, 2020 - 2023, USD Million
TABLE 37 Europe IoT Market by Country, 2024 - 2031, USD Million
TABLE 38 Europe Blockchain Technology Market by Country, 2020 - 2023, USD Million
TABLE 39 Europe Blockchain Technology Market by Country, 2024 - 2031, USD Million
TABLE 40 Europe Other Technology Market by Country, 2020 - 2023, USD Million
TABLE 41 Europe Other Technology Market by Country, 2024 - 2031, USD Million
TABLE 42 Europe Pharma 4.0 Market by Country, 2020 - 2023, USD Million
TABLE 43 Europe Pharma 4.0 Market by Country, 2024 - 2031, USD Million
TABLE 44 Germany Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 45 Germany Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 46 Germany Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 47 Germany Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 48 Germany Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 49 Germany Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 50 Germany Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 51 Germany Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 52 Germany Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 53 Germany Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 54 UK Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 55 UK Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 56 UK Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 57 UK Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 58 UK Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 59 UK Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 60 UK Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 61 UK Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 62 UK Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 63 UK Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 64 France Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 65 France Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 66 France Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 67 France Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 68 France Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 69 France Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 70 France Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 71 France Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 72 France Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 73 France Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 74 Russia Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 75 Russia Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 76 Russia Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 77 Russia Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 78 Russia Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 79 Russia Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 80 Russia Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 81 Russia Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 82 Russia Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 83 Russia Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 84 Spain Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 85 Spain Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 86 Spain Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 87 Spain Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 88 Spain Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 89 Spain Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 90 Spain Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 91 Spain Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 92 Spain Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 93 Spain Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 94 Italy Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 95 Italy Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 96 Italy Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 97 Italy Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 98 Italy Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 99 Italy Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 100 Italy Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 101 Italy Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 102 Italy Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 103 Italy Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 104 Rest of Europe Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 105 Rest of Europe Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 106 Rest of Europe Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 107 Rest of Europe Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 108 Rest of Europe Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 109 Rest of Europe Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 110 Rest of Europe Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 111 Rest of Europe Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 112 Rest of Europe Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 113 Rest of Europe Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 114 Key Information - Amazon Web Services, Inc.
TABLE 115 Key Information - Oracle Corporation
TABLE 116 Key Information - Microsoft Corporation
TABLE 117 Key Information - IBM Corporation
TABLE 118 Key Information - SAP SE
TABLE 119 Key Information - GE HealthCare Technologies, Inc.
TABLE 120 Key Information - Siemens Healthineers AG
TABLE 121 Key Information - Cisco Systems, Inc.
TABLE 122 Key Information - Dassault Systemes SE
TABLE 123 Key Information - UnitedHealth Group, Inc.

Europe Pharma 4.0 Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Technology, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents